Connor, Clark & Lunn Investment Management (CC&L)’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.1M | Buy |
685,511
+190,334
| +38% | +$2.82M | 0.04% | 398 |
|
|
2025
Q1 | $8.87M | Buy |
495,177
+68,451
| +16% | +$1.23M | 0.04% | 352 |
|
|
2024
Q4 | $7.43M | Sell |
426,726
-98,655
| -19% | -$1.72M | 0.03% | 386 |
|
|
2024
Q3 | $7.35M | Buy |
525,381
+52,985
| +11% | +$741K | 0.04% | 347 |
|
|
2024
Q2 | $3.88M | Buy |
472,396
+55,743
| +13% | +$458K | 0.02% | 491 |
|
|
2024
Q1 | $3.21M | Buy |
416,653
+128,842
| +45% | +$993K | 0.01% | 537 |
|
|
2023
Q4 | $2.59M | Sell |
287,811
-3,022
| -1% | -$27.2K | 0.01% | 603 |
|
|
2023
Q3 | $2.6M | Sell |
290,833
-78
| -0% | -$697 | 0.01% | 546 |
|
|
2023
Q2 | $4.47M | Buy |
290,911
+13,899
| +5% | +$213K | 0.02% | 423 |
|
|
2023
Q1 | $6.23M | Buy |
277,012
+32,200
| +13% | +$724K | 0.03% | 329 |
|
|
2022
Q4 | $5.15M | Sell |
244,812
-2,037
| -0.8% | -$42.8K | 0.03% | 354 |
|
|
2022
Q3 | $6.08M | Buy |
246,849
+9,298
| +4% | +$229K | 0.04% | 285 |
|
|
2022
Q2 | $5.76M | Buy |
237,551
+1,777
| +0.8% | +$43.1K | 0.04% | 283 |
|
|
2022
Q1 | $6.08M | Buy |
235,774
+5,405
| +2% | +$139K | 0.03% | 298 |
|
|
2021
Q4 | $7.15M | Buy |
230,369
+62,119
| +37% | +$1.93M | 0.03% | 285 |
|
|
2021
Q3 | $4.08M | Buy |
+168,250
| New | +$4.08M | 0.02% | 377 |
|
|
2021
Q1 | – | Sell |
-12,388
| Closed | -$338K | – | 1095 |
|
|
2020
Q4 | $338K | Buy |
+12,388
| New | +$338K | ﹤0.01% | 772 |
|
|
2018
Q4 | – | Sell |
-13,150
| Closed | -$378K | – | 1051 |
|
|
2018
Q3 | $378K | Sell |
13,150
-10,440
| -44% | -$300K | ﹤0.01% | 748 |
|
|
2018
Q2 | $643K | Sell |
23,590
-16,227
| -41% | -$442K | ﹤0.01% | 714 |
|
|
2018
Q1 | $890K | Sell |
39,817
-600
| -1% | -$13.4K | 0.01% | 496 |
|
|
2017
Q4 | $852K | Sell |
40,417
-14,208
| -26% | -$300K | 0.01% | 542 |
|
|
2017
Q3 | $1.36M | Sell |
54,625
-17,425
| -24% | -$434K | 0.01% | 481 |
|
|
2017
Q2 | $1.4M | Buy |
72,050
+41,700
| +137% | +$809K | 0.01% | 445 |
|
|
2017
Q1 | $560K | Buy |
+30,350
| New | +$560K | ﹤0.01% | 609 |
|
|
2016
Q3 | – | Sell |
-20,950
| Closed | -$373K | – | 917 |
|
|
2016
Q2 | $373K | Sell |
20,950
-88,800
| -81% | -$1.58M | ﹤0.01% | 639 |
|
|
2016
Q1 | $1.5M | Sell |
109,750
-39,300
| -26% | -$537K | 0.01% | 384 |
|
|
2015
Q4 | $2.88M | Buy |
149,050
+3,900
| +3% | +$75.2K | 0.02% | 281 |
|
|
2015
Q3 | $2.94M | Sell |
145,150
-8,200
| -5% | -$166K | 0.02% | 250 |
|
|
2015
Q2 | $5.08M | Sell |
153,350
-29,550
| -16% | -$980K | 0.05% | 156 |
|
|
2015
Q1 | $4.38M | Buy |
182,900
+43,300
| +31% | +$1.04M | 0.04% | 162 |
|
|
2014
Q4 | $1.71M | Buy |
139,600
+53,000
| +61% | +$649K | 0.01% | 249 |
|
|
2014
Q3 | $781K | Buy |
+86,600
| New | +$781K | 0.01% | 340 |
|